Filing Details
- Accession Number:
- 0001140361-12-025869
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-05-16 17:47:31
- Reporting Period:
- 2012-05-15
- Filing Date:
- 2012-05-16
- Filing Date Changed:
- 2012-05-16
- Accepted Time:
- 2012-05-16 17:47:31
- Original Submission Date:
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 318306 | Access Pharmaceuticals Inc | ACCP | Pharmaceutical Preparations (2834) | 830221517 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1413350 | Jay Venkatesan | 230 California Street, Suite 600 San Francisco CA 94111 |
No | No | Yes | No | |
| 1471149 | Ayer Capital Management, Lp | 230 California, Suite 600 San Francisco CA 94111 |
No | No | Yes | No | |
| 1519940 | Acm Capital Partners, Llc | 230 California Street, Suite 600 San Francisco CA 94111 |
No | No | Yes | No | |
| 1519942 | Ayer Capital Partners, Llc | 230 California Street, Suite 600 San Francisco CA 94111 |
No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings |
|---|---|---|---|---|---|
| Common Stock | Disposition | 2012-05-16 | 140,300 | $0.67 | 2,617,320 |
| Common Stock | Disposition | 2012-05-15 | 1,000 | $0.85 | 2,757,620 |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | See footnote |
| No | 4 | S | Indirect | See footnote |
Footnotes
- These securities are held by investment funds and a managed account, the investment advisor of which is Ayer Capital Management, LP (the "Advisor"). ACM Capital Partners, LLC(the "ACM") is the General Partner of the Advisor, Ayer Capital Parnters, LLC is the General Partner (the "GP") of the investment funds. Mr. Venkatesan is the managing member of ACM and the general partner of the GP.
- Each of the Advisor, ACM, the GP, Ayer Capital Partners, LLC and Mr. Venkatesan disclaims beneficial ownership of these securities except to the extent of its or his pecuniary interest thereof, and the filing of this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purpose.
Insider Monkey Small Cap Strategy
Insider Monkey beat the market by 20 percentage points in 6 months - Learn how!
